14th annual report: Top 100 biotechnology companies back to table of contents <a href="http://www.pharmalive.com/magazines/medad/view.cfm?articleID=2302";>Med Ad News</a>
Over the Line: As the biotechnology industry outpaces traditional pharmaceuticals, the biotechnology leaders are taking top spots from big pharma peers. At the other end, small, emerging biotechnology companies struggle to find funding among risk-averse investors. by Med Ad News Staff Notes to Charts Methodology REVENUE: Top 100 biotechnology companies (table) RESEARCH & DEVELOPMENT: Top 100 biotechnology companies (table) EMPLOYEES: Top 100 biotechnology companies (table) LOCATION, YEAR ESTABLISHED: Top 100 biotechnology companies (table) As biotechnology companies merge and grow, they are rising in the ranks of the top companies overall. Traditional pharmaceutical companies, meanwhile, are partnering with the biotechnology sector to fill dry pipelines and to replace the dwindling blockbusters. Industry analysts believe that the growth of the biotechnology industry, led by Amgen Inc. and Genentech Inc., will continue to outpace that of pharmaceutical companies. According to Wood Mackenzie analysts, the seven largest biotechnology companies are growing at rates faster than the pharmaceutical industrys 9.1% average. Amgen is now ranked among the top 20 global pharmaceutical companies in the world and will break into the top 10 by 2008, Wood Mackenzie analysts say. In addition, five of the 10 largest mergers and acquisitions in 2003 were within the biotechnology sector, indicating continued growth and maturity. "Our research shows what the industry has suspected: biotechnology companies have truly come into their own," says Jim Hall, life-sciences president, Wood Mackenzie (woodmac.com). "As biotechs increasingly retain ownership of their developmental compounds and create more targeted blockbuster drugs, they will grow faster than pharmaceutical companies." Biotechnology companies will continue to take prominent positions among the top pharmaceutical companies, according to James A. Lebovitz, partner and chair, the business and technology group, Dechert LLP (dechert.com), and a member of Decherts health law group. "Right now, you can distinguish between the Pfizers and the Mercks, and the Amgens, Biogen Idecs, and Genentechs, but the distinctions are becoming fewer and fewer," he says. "As more biotech companies get bigger products that are just huge revenue generators, they will start to be mentioned in the same breath as those pharmaceutical companies." http://www.arizonabiotech.com/ <a href="http://www.arizonabiotech.com/";>Arizona Biotech</a> http://groups.yahoo.com/group/biotech-news/ <a href="http://groups.yahoo.com/group/biotech-news/";>Biotech News</a> http://www.arizonaentrepreneurs.com/ <a href="http://www.arizonaentrepreneurs.com/";>Arizona Entrepreneurs</a> http://www.azhttp.com/ <a href="http://www.azhttp.com/";>Arizona High Tech</a> <a href="http://www.arizonabiotech.com/index.php";>Biotechnology News Forums</a> http://www.arizonabiotech.com/ <a href="http://www.arizonabiotech.com/";>Arizona Biotech</a> http://groups.yahoo.com/group/biotech-news/ <a href="http://groups.yahoo.com/group/biotech-news/";>Biotech News</a> http://www.arizonaentrepreneurs.com/ <a href="http://www.arizonaentrepreneurs.com/";>Arizona Entrepreneurs</a> http://www.azhttp.com/ <a href="http://www.azhttp.com/";>Arizona High Tech</a> Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
